 | Up a level |
Sehr, T; Proschmann, U; Thomas, K; Marggraf, M; Straube, E; Reichmann, H; Chan, Andrew; Ziemssen, T (2016). New insights into the pharmacokinetics and pharmacodynamics of natalizumab treatment for patients with multiple sclerosis, obtained from clinical and in vitro studies. Journal of neuroinflammation, 13(1), p. 164. BioMed Central 10.1186/s12974-016-0635-2
Diener, HC; Weimar, C; Berlit, P; Dueschl, G; Elger, C; Gold, R; Hacke, W; Hufschmidt, A; Mattle, H; Meier, U; Oertel, WH; Reichmann, H; Schmutzhard, E; Wallesch, C-W; Weller, M (eds.) (2012). Leitlinien für Diagnostik und Therapie in der Neurologie. 5. vollständig überarbeitete Auflage. Stuttgart: Thieme
